• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性疼痛药物:等效水平及用量量化方法

Chronic-pain medications: equivalence levels and method of quantifying usage.

作者信息

Masters Steedman S, Middaugh S J, Kee W G, Carson D S, Harden R N, Miller M C

机构信息

Department of Pharmacy Services, Medical University of South Carolina, Charleston 29425.

出版信息

Clin J Pain. 1992 Sep;8(3):204-14.

PMID:1421733
Abstract

Medication use is an important consideration in chronic-pain rehabilitation programs (CPRPs). However, it is difficult to quantify this aspect of chronic-pain treatment, because patients often take multiple medications that can differ by pharmacological class as well as dosage level. The Medication Quantification Scale (MQS) provides a method for quantifying medication use in patients with chronic, nonmalignant pain. Scores are calculated for each medication based on weights assigned by medication class and dosage level, and these scores are summed to provide a quantitative index of total medication usage suitable for statistical analysis. The method for calculating MQS scores is illustrated, and research data on MQS reliability and validity are presented. Interrater reliability was rho = 0.985 (p less than 0.0001) for 30 MQS scores calculated by two clinicians. MQS scores for 88 patients correlated well with the clinical judgment of 12 health care professionals (mean rho = 0.755, p less than 0.0001). The MQS scores for 60 chronic-pain patients (30 treated in a CPRP and 30 untreated) were obtained at two time points: evaluation and 1-year follow-up. A two (groups) by two (time points) analysis of variance yielded a significant group-by-time interaction (F = 8.82, p less than 0.0043). Treated patients decreased their medication intake significantly (p less than 0.0001), whereas untreated patients did not (p greater than 0.57). The MQS offers a reliable and valid method for quantifying medication usage in chronic-pain patients.

摘要

药物使用是慢性疼痛康复项目(CPRPs)中的一个重要考量因素。然而,量化慢性疼痛治疗的这一方面很困难,因为患者通常服用多种药物,这些药物在药理类别和剂量水平上可能存在差异。药物量化量表(MQS)提供了一种量化慢性非恶性疼痛患者药物使用情况的方法。根据药物类别和剂量水平分配的权重为每种药物计算得分,这些得分相加可提供一个适合统计分析的药物总使用量的定量指标。文中说明了计算MQS得分的方法,并展示了关于MQS可靠性和有效性的研究数据。两位临床医生计算的30个MQS得分的评分者间信度为rho = 0.985(p小于0.0001)。88名患者的MQS得分与12名医疗保健专业人员的临床判断相关性良好(平均rho = 0.755,p小于0.0001)。在两个时间点获取了60名慢性疼痛患者(30名在CPRP中接受治疗,30名未接受治疗)的MQS得分:评估时和1年随访时。两因素(组)×两因素(时间点)方差分析产生了显著的组×时间交互作用(F = 8.82,p小于0.0043)。接受治疗的患者药物摄入量显著减少(p小于0.0001),而未接受治疗的患者则没有(p大于0.57)。MQS为量化慢性疼痛患者的药物使用情况提供了一种可靠且有效的方法。

相似文献

1
Chronic-pain medications: equivalence levels and method of quantifying usage.慢性疼痛药物:等效水平及用量量化方法
Clin J Pain. 1992 Sep;8(3):204-14.
2
Medication Quantification Scale Version III: internal validation of detriment weights using a chronic pain population.药物量化量表第三版:使用慢性疼痛人群对损害权重进行内部验证
Pain Pract. 2008 Jan-Feb;8(1):1-4. doi: 10.1111/j.1533-2500.2007.00163.x.
3
Medication Quantification Scale Version III: update in medication classes and revised detriment weights by survey of American Pain Society Physicians.药物量化量表第三版:通过对美国疼痛学会医生的调查对药物类别进行更新并修订损害权重。
J Pain. 2005 Jun;6(6):364-71. doi: 10.1016/j.jpain.2005.01.350.
4
Quantification of analgesic use in children with sickle cell disease.镰状细胞病患儿镇痛药物使用的量化分析
Clin J Pain. 2007 Jan;23(1):8-14. doi: 10.1097/01.ajp.0000210938.58439.dd.
5
Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain.氢可酮与布洛芬联合用药对比可待因与对乙酰氨基酚联合用药治疗慢性疼痛
Clin Ther. 2000 Jul;22(7):879-92. doi: 10.1016/S0149-2918(00)80060-0.
6
Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: a prospective analysis of admission, discharge, and 6-month follow-up medication costs.完成疼痛康复计划的慢性非恶性疼痛患者的药物成本降低:入院、出院及6个月随访药物成本的前瞻性分析
Pain Med. 2009 Jul-Aug;10(5):787-96. doi: 10.1111/j.1526-4637.2009.00582.x. Epub 2009 Mar 19.
7
The Medication Quantification Scale 4.0: An Updated Index Based on Prescribers' Perceptions of the Risk Associated With Chronic Pain Medications.《药物量化量表 4.0:基于处方者对慢性疼痛药物相关风险认知的更新指标》。
J Pain. 2024 Feb;25(2):508-521. doi: 10.1016/j.jpain.2023.09.010. Epub 2023 Oct 13.
8
Assessing the appropriateness of pain medication prescribing practices in nursing homes.评估疗养院中止痛药物处方做法的适当性。
J Am Geriatr Soc. 2006 Feb;54(2):231-9. doi: 10.1111/j.1532-5415.2005.00582.x.
9
Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.用于治疗慢性下腰痛的羟吗啡酮缓释剂:根据年龄、性别和既往阿片类药物使用情况分层的富集入组临床试验数据的回顾性汇总分析
Clin Ther. 2009 Feb;31(2):347-59. doi: 10.1016/j.clinthera.2009.02.019.
10
Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.非典型抗精神病药物中毒:院外管理的循证共识指南
Clin Toxicol (Phila). 2007 Dec;45(8):918-42. doi: 10.1080/15563650701665142.

引用本文的文献

1
Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study.脊髓刺激治疗慢性脊柱疼痛综合征 II 型患者的疼痛药物逐渐减量:PIANISSIMO 研究的 RCT 研究方案。
PLoS One. 2024 Aug 12;19(8):e0302842. doi: 10.1371/journal.pone.0302842. eCollection 2024.
2
Comparison of clinical outcomes associated with spinal cord stimulation (SCS) or conventional medical management (CMM) for chronic pain: a systematic review and meta-analysis.比较脊髓刺激 (SCS) 与常规药物治疗 (CMM) 治疗慢性疼痛的临床结局:系统评价和荟萃分析。
Eur Spine J. 2023 Jun;32(6):2029-2041. doi: 10.1007/s00586-023-07716-2. Epub 2023 Apr 17.
3
Bicentre, randomized, parallel-arm, sham-controlled trial of transcranial direct-current stimulation (tDCS) in the treatment of palliative care patients with refractory cancer pain.
双中心、随机、平行臂、假刺激对照试验,评估经颅直流电刺激(tDCS)治疗难治性癌痛姑息治疗患者的效果。
BMC Palliat Care. 2023 Feb 28;22(1):15. doi: 10.1186/s12904-023-01129-0.
4
Proportion of clinical holistic responders in patients with persistent spinal pain syndrome type II treated by subthreshold spinal cord stimulation compared to best medical treatment: a study protocol for a multicentric randomised controlled trial (TRADITION).亚阈值脊髓电刺激治疗持续性脊柱疼痛综合征 II 型患者的临床整体反应者比例与最佳药物治疗相比:一项多中心随机对照试验(TRADITION)的研究方案。
Trials. 2023 Feb 20;24(1):120. doi: 10.1186/s13063-023-07140-3.
5
Predicting the Response of High Frequency Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome: A Retrospective Study with Machine Learning Techniques.预测腰椎手术失败综合征患者高频脊髓刺激的反应:一项采用机器学习技术的回顾性研究
J Clin Med. 2020 Dec 21;9(12):4131. doi: 10.3390/jcm9124131.
6
A randomized controlled TRIal of cognitive BEhavioral therapy for high Catastrophizing in patients undergoing lumbar fusion surgery: the TRIBECA study.一项针对接受腰椎融合手术患者的高灾难化认知行为疗法的随机对照试验:TRIBECA 研究。
BMC Musculoskelet Disord. 2020 Dec 4;21(1):810. doi: 10.1186/s12891-020-03826-w.
7
Determining the Minimal Clinical Important Difference for Medication Quantification Scale III and Morphine Milligram Equivalents in Patients with Failed Back Surgery Syndrome.确定腰椎手术失败综合征患者药物量化量表III及吗啡毫克当量的最小临床重要差异。
J Clin Med. 2020 Nov 21;9(11):3747. doi: 10.3390/jcm9113747.
8
Caregiver-guided pain coping skills training for patients with advanced cancer: Background, design, and challenges for the CaringPals study.照顾者引导的晚期癌症患者疼痛应对技能培训:CaringPals 研究的背景、设计和挑战。
Clin Trials. 2019 Jun;16(3):263-272. doi: 10.1177/1740774519829695. Epub 2019 Feb 19.
9
Development of a screening tool to predict the risk of chronic pain and disability following musculoskeletal trauma: protocol for a prospective observational study in the United Kingdom.开发一种筛查工具以预测肌肉骨骼创伤后慢性疼痛和残疾的风险:英国一项前瞻性观察性研究的方案
BMJ Open. 2018 Apr 28;8(4):e017876. doi: 10.1136/bmjopen-2017-017876.
10
Long-term effect of motor cortex stimulation in patients suffering from chronic neuropathic pain: An observational study.运动皮层刺激对慢性神经性疼痛患者的长期影响:一项观察性研究。
PLoS One. 2018 Jan 30;13(1):e0191774. doi: 10.1371/journal.pone.0191774. eCollection 2018.